A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL)

Condition:   CTCL Intervention:   Drug: ABT-199 (venetoclax) Sponsor:   Yale University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials